These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 35255751

  • 1. In silico drug discovery of melatonin receptor ligands with therapeutic potential.
    Elisi GM, Scalvini L, Lodola A, Bedini A, Spadoni G, Rivara S.
    Expert Opin Drug Discov; 2022 Apr; 17(4):343-354. PubMed ID: 35255751
    [Abstract] [Full Text] [Related]

  • 2. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.
    Stein RM, Kang HJ, McCorvy JD, Glatfelter GC, Jones AJ, Che T, Slocum S, Huang XP, Savych O, Moroz YS, Stauch B, Johansson LC, Cherezov V, Kenakin T, Irwin JJ, Shoichet BK, Roth BL, Dubocovich ML.
    Nature; 2020 Mar; 579(7800):609-614. PubMed ID: 32040955
    [Abstract] [Full Text] [Related]

  • 3. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
    Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML.
    Annu Rev Pharmacol Toxicol; 2016 Mar; 56():361-83. PubMed ID: 26514204
    [Abstract] [Full Text] [Related]

  • 4. Structure-based discovery of potent and selective melatonin receptor agonists.
    Patel N, Huang XP, Grandner JM, Johansson LC, Stauch B, McCorvy JD, Liu Y, Roth B, Katritch V.
    Elife; 2020 Mar 02; 9():. PubMed ID: 32118583
    [Abstract] [Full Text] [Related]

  • 5. Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle.
    López-Canul M, Min SH, Posa L, De Gregorio D, Bedini A, Spadoni G, Gobbi G, Comai S.
    Int J Mol Sci; 2019 May 17; 20(10):. PubMed ID: 31108968
    [Abstract] [Full Text] [Related]

  • 6. Docking studies for melatonin receptors.
    Alkozi HA, Sánchez Montero JM, Doadrio AL, Pintor J.
    Expert Opin Drug Discov; 2018 Mar 17; 13(3):241-248. PubMed ID: 29271261
    [Abstract] [Full Text] [Related]

  • 7. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V, Mailliet F, Lahaye-Brasseur C, Bonnaud A, Le Gall A, Amossé C, Dromaint S, Rodriguez M, Nagel N, Galizzi JP, Malpaux B, Guillaumet G, Lesieur D, Lefoulon F, Renard P, Delagrange P, Boutin JA.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun 17; 367(6):553-61. PubMed ID: 12764576
    [Abstract] [Full Text] [Related]

  • 8. Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus.
    Pévet P.
    Expert Opin Ther Targets; 2016 Oct 17; 20(10):1209-18. PubMed ID: 27082492
    [Abstract] [Full Text] [Related]

  • 9. Recent advances in melatonin receptor ligands.
    Zlotos DP.
    Arch Pharm (Weinheim); 2005 Jun 17; 338(5-6):229-47. PubMed ID: 15952241
    [Abstract] [Full Text] [Related]

  • 10. Structural basis of ligand recognition at the human MT1 melatonin receptor.
    Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, Gati C, Batyuk A, Slocum ST, Ishchenko A, Brehm W, White TA, Michaelian N, Madsen C, Zhu L, Grant TD, Grandner JM, Shiriaeva A, Olsen RHJ, Tribo AR, Yous S, Stevens RC, Weierstall U, Katritch V, Roth BL, Liu W, Cherezov V.
    Nature; 2019 May 17; 569(7755):284-288. PubMed ID: 31019306
    [Abstract] [Full Text] [Related]

  • 11. XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity.
    Johansson LC, Stauch B, McCorvy JD, Han GW, Patel N, Huang XP, Batyuk A, Gati C, Slocum ST, Li C, Grandner JM, Hao S, Olsen RHJ, Tribo AR, Zaare S, Zhu L, Zatsepin NA, Weierstall U, Yous S, Stevens RC, Liu W, Roth BL, Katritch V, Cherezov V.
    Nature; 2019 May 17; 569(7755):289-292. PubMed ID: 31019305
    [Abstract] [Full Text] [Related]

  • 12. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP, Jockers R, Cecon E, Rivara S, Witt-Enderby PA.
    J Med Chem; 2014 Apr 24; 57(8):3161-85. PubMed ID: 24228714
    [Abstract] [Full Text] [Related]

  • 13. Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives.
    Comai S, Lopez-Canul M, De Gregorio D, Posner A, Ettaoussi M, Guarnieri FC, Gobbi G.
    Pharmacol Res; 2019 Jun 24; 144():343-356. PubMed ID: 31029764
    [Abstract] [Full Text] [Related]

  • 14. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states.
    Ochoa-Sanchez R, Comai S, Spadoni G, Bedini A, Tarzia G, Gobbi G.
    Neurosci Lett; 2014 Feb 21; 561():156-61. PubMed ID: 24406151
    [Abstract] [Full Text] [Related]

  • 15. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
    Lucini V, Pannacci M, Scaglione F, Fraschini F, Rivara S, Mor M, Bordi F, Plazzi PV, Spadoni G, Bedini A, Piersanti G, Diamantini G, Tarzia G.
    J Med Chem; 2004 Aug 12; 47(17):4202-12. PubMed ID: 15293992
    [Abstract] [Full Text] [Related]

  • 16. Melatonin receptor ligands: A pharmaco-chemical perspective.
    Boutin JA, Witt-Enderby PA, Sotriffer C, Zlotos DP.
    J Pineal Res; 2020 Oct 12; 69(3):e12672. PubMed ID: 32531076
    [Abstract] [Full Text] [Related]

  • 17. [Sites and mechanisms of action of melatonin in mammals: the MT1 and MT2 receptors].
    Schuster C.
    J Soc Biol; 2007 Oct 12; 201(1):85-96. PubMed ID: 17762828
    [Abstract] [Full Text] [Related]

  • 18. A molecular and chemical perspective in defining melatonin receptor subtype selectivity.
    Chan KH, Wong YH.
    Int J Mol Sci; 2013 Sep 06; 14(9):18385-406. PubMed ID: 24018885
    [Abstract] [Full Text] [Related]

  • 19. Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression.
    Boiko DI, Shkodina AD, Hasan MM, Bardhan M, Kazmi SK, Chopra H, Bhutra P, Baig AA, Skrypnikov AM.
    Neurochem Res; 2022 Oct 06; 47(10):2909-2924. PubMed ID: 35689787
    [Abstract] [Full Text] [Related]

  • 20. Investigational selective melatoninergic ligands for receptor subtype MT2.
    Wan N, Zhang FF, Ju J, Liu DZ, Zhou SY, Zhang BL.
    Mini Rev Med Chem; 2013 Aug 06; 13(10):1462-74. PubMed ID: 23815579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.